343 related articles for article (PubMed ID: 15693809)
1. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
Kaynak D; Kiziltan G; Kaynak H; Benbir G; Uysal O
Eur J Neurol; 2005 Mar; 12(3):199-207. PubMed ID: 15693809
[TBL] [Abstract][Full Text] [Related]
2. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
[TBL] [Abstract][Full Text] [Related]
3. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
[TBL] [Abstract][Full Text] [Related]
4. Sleepiness in Parkinson's disease: a controlled study.
Brodsky MA; Godbold J; Roth T; Olanow CW
Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
[TBL] [Abstract][Full Text] [Related]
5. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Razmy A; Lang AE; Shapiro CM
Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
[TBL] [Abstract][Full Text] [Related]
6. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
Dusek P; Busková J; Růzicka E; Majerová V; Srp A; Jech R; Roth J; Sonka K
Clin Neuropharmacol; 2010 Jul; 33(4):186-90. PubMed ID: 20661025
[TBL] [Abstract][Full Text] [Related]
7. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
Möller JC; Stiasny K; Hargutt V; Cassel W; Tietze H; Peter JH; Krüger HP; Oertel WH
Mov Disord; 2002 May; 17(3):474-81. PubMed ID: 12112193
[TBL] [Abstract][Full Text] [Related]
9. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study.
Shpirer I; Miniovitz A; Klein C; Goldstein R; Prokhorov T; Theitler J; Pollak L; Rabey JM
Mov Disord; 2006 Sep; 21(9):1432-8. PubMed ID: 16773617
[TBL] [Abstract][Full Text] [Related]
10. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
Valko PO; Waldvogel D; Weller M; Bassetti CL; Held U; Baumann CR
Eur J Neurol; 2010 Dec; 17(12):1428-36. PubMed ID: 20491889
[TBL] [Abstract][Full Text] [Related]
11. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
Gómez-Esteban JC; Zarranz JJ; Lezcano E; Velasco F; Ciordia R; Rouco I; Losada J; Bilbao I
Mov Disord; 2006 Jul; 21(7):983-8. PubMed ID: 16602112
[TBL] [Abstract][Full Text] [Related]
12. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
Del Dotto P; Gambaccini G; Caneparo D; Berti C; Bernardini S; Bonuccelli U
Neurol Sci; 2003 Oct; 24(3):170-1. PubMed ID: 14598071
[TBL] [Abstract][Full Text] [Related]
13. Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?
Sixel-Döring F; Trautmann E; Mollenhauer B; Trenkwalder C
Sleep Med; 2012 Oct; 13(9):1178-83. PubMed ID: 22841842
[TBL] [Abstract][Full Text] [Related]
14. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
Romigi A; Brusa L; Marciani MG; Pierantozzi M; Placidi F; Izzi F; Sperli F; Testa F; Stanzione P
J Neurol Sci; 2005 Jan; 228(1):7-10. PubMed ID: 15607203
[TBL] [Abstract][Full Text] [Related]
15. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
Chahine LM; Daley J; Horn S; Duda JE; Colcher A; Hurtig H; Cantor C; Dahodwala N
Parkinsonism Relat Disord; 2013 Oct; 19(10):859-63. PubMed ID: 23751512
[TBL] [Abstract][Full Text] [Related]
16. [The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
Nodel MR; Shevtsova KV; Kovrov GV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):102-108. PubMed ID: 36279235
[TBL] [Abstract][Full Text] [Related]
17. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
[TBL] [Abstract][Full Text] [Related]
18. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
Happe S; Baier PC; Helmschmied K; Meller J; Tatsch K; Paulus W
J Neurol; 2007 Aug; 254(8):1037-43. PubMed ID: 17351722
[TBL] [Abstract][Full Text] [Related]
19. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550
[TBL] [Abstract][Full Text] [Related]
20. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study.
Happe S; Berger K;
J Neurol; 2001 Dec; 248(12):1062-7. PubMed ID: 12013583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
